These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 26857862

  • 1. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
    Wang Y, Li YM, Zhang S, Zhao JY, Liu CY.
    J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
    [Abstract] [Full Text] [Related]

  • 2. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M, Elhefnawy KA, Emad G, Ismail M, Borai M.
    J Bras Nefrol; 2019 Apr; 41(4):509-517. PubMed ID: 30897192
    [Abstract] [Full Text] [Related]

  • 3. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A, Dumnicka P, Kuśnierz-Cabala B, Gala-Błądzińska A, Ceranowicz P, Kucharz J, Ząbek-Adamska A, Maziarz B, Drożdż R, Kuźniewski M.
    Mediators Inflamm; 2018 Apr; 2018():7659243. PubMed ID: 30158836
    [Abstract] [Full Text] [Related]

  • 4. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH.
    Cardiovasc Diabetol; 2016 Jan 07; 15():3. PubMed ID: 26739836
    [Abstract] [Full Text] [Related]

  • 5. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C, Wang Q, Lv C, Qin N, Lei S, Yuan Q, Wang G.
    Diabetes Res Clin Pract; 2014 Nov 07; 106(2):343-50. PubMed ID: 25263500
    [Abstract] [Full Text] [Related]

  • 6. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
    Chou ST, Tseng ST.
    Clin Exp Nephrol; 2017 Apr 07; 21(2):283-292. PubMed ID: 27233502
    [Abstract] [Full Text] [Related]

  • 7. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z, Xu Y, Liu X, Nie Y, Zhao Z.
    Nephrology (Carlton); 2017 Jan 07; 22(1):58-64. PubMed ID: 26733347
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S, Hamide A, Senthilkumar GP, Mehalingam V.
    Diabetes Metab Syndr; 2018 Sep 07; 12(5):649-652. PubMed ID: 29673928
    [Abstract] [Full Text] [Related]

  • 10. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
    Tan SMQ, Chiew Y, Ahmad B, Kadir KA.
    Nutrients; 2018 Sep 17; 10(9):. PubMed ID: 30227659
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The potential use of urinary transferrin, urinary adiponectin, urinary Retinol Binding Protein, and serum zinc alpha 2 glycoprotein levels as novel biomarkers for early diagnosis of diabetic nephropathy: A case-control study.
    Kamel MF, Nassar M, Elbendary A, Mohamed AGA, Abdullah MG, Gomaa HRA, Awad EMI, Mahmoud HH, Elfiki MA, Abdalla NH, Abd Elkareem RM, Soliman AS, Elmessiery RM.
    Diabetes Metab Syndr; 2022 Apr 17; 16(4):102473. PubMed ID: 35405355
    [Abstract] [Full Text] [Related]

  • 13. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
    Shiju TM, Mohan V, Balasubramanyam M, Viswanathan P.
    J Diabetes Complications; 2015 Apr 17; 29(3):400-6. PubMed ID: 25619588
    [Abstract] [Full Text] [Related]

  • 14. Early vascular parameters in the micro- and macrocirculation in type 2 diabetes.
    Kannenkeril D, Bosch A, Harazny J, Karg M, Jung S, Ott C, Schmieder RE.
    Cardiovasc Diabetol; 2018 Sep 19; 17(1):128. PubMed ID: 30231923
    [Abstract] [Full Text] [Related]

  • 15. PTPN2 Downregulation Is Associated with Albuminuria and Vitamin D Receptor Deficiency in Type 2 Diabetes Mellitus.
    Zheng L, Zhang W, Li A, Liu Y, Yi B, Nakhoul F, Zhang H.
    J Diabetes Res; 2018 Sep 19; 2018():3984797. PubMed ID: 30246029
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC, Frenay AR, Bakker SJ, Pasch A, Hillebrands JL, Lambers Heerspink HJ, van Goor H.
    Nitric Oxide; 2016 May 01; 55-56():18-24. PubMed ID: 26952289
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A, Bdeer Sel-A, El-Sokkary RH.
    Mol Cell Biochem; 2015 Oct 01; 408(1-2):25-35. PubMed ID: 26104579
    [Abstract] [Full Text] [Related]

  • 20. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
    Idowu AA, Ajose AO, Adedeji AT, Adegoke AO, Jimoh KA.
    Ghana Med J; 2017 Jun 01; 51(2):56-63. PubMed ID: 28955101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.